Bluebee and MediSapiens Announce Strategic Partnership

Combined Offering Provides a Comprehensive Integrated Solution For (NGS) Data Analysis And Interpretation in Healthcare And Research Finland and The Netherlands – May 29, 2017 – Today, Bluebee, a leading provider of high-performance genomics analysis and storage solutions and MediSapiens, a leading biomedical big data curation, management and interpretation company, announce a strategic partnership to provide... Read more

GEs Tatabanya, Hungary, Facility Expands Production of ISO-Accredited Reference Material

TREVOSE, PA.—May 24, 2017 Analytical Instruments, a Division of GE Water & Process Technologies, Produces Sievers* Total Organic Carbon Analyzers GE’s Tatabanya, Hungary, Facility Expanded Production Capabilities to Include Certified Reference Materials Reference Materials Produced On-site Have Received Prestigious ISO Guide 34 and ISO/IEC 17025 Accreditation Analytical Instruments, a division of GE Water & Process... Read more

Fabric Genomics Partners with European Server Provider ITTM to Deliver Secure Genomic Analysis in Europe

May 24, 2017 05:00 AM Pacific Daylight Time OAKLAND, Calif. & BOSTON & COPENHAGEN, Denmark–(BUSINESS WIRE)–Fabric Genomics, a global computational genomics company offering data analysis and clinical reporting tools, announced today that it has partnered with data management company ITTM S.A. (Information Technology for Translational Medicine) to provide secure genomic data hosting capabilities for EU... Read more

DNAnexus to Partner With AstraZeneca’s Centre for Genomics Research

Companies partner to develop secure genomics informatics environment for AstraZeneca’s initiative to analyse two million genomes May 23, 2017 04:30 AM Pacific Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the global leader in genome informatics and data management, today announced that its secure cloud-based platform has been selected as a partner for AstraZeneca’s Centre for... Read more

Seegene enters the U.S. diagnostic market in collaboration with Thermo Fisher Scientific

PR Newswire 2017.05.22 Seoul, Korea, 2017/05/22 – Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, today announced that it has entered into a new strategic collaboration relationship with Thermo Fisher Scientific in which Seegene will file for U.S Food and Drug Administration (FDA) clearance of its AllplexTM diagnostic assay... Read more

GE Healthcare’s FlexFactory to power Dr. Reddy’s biosimilar expansion plans

CHALFONT ST. GILES, UK and Bangalore, INDIA – 18 May 2017 – GE Healthcare today announced that Dr. Reddy’s Laboratories Limited will install India’s first-ever FlexFactory, a single-use manufacturing platform to expand the biologics production capacity at its facility in Hyderabad, India. FlexFactory will make Dr. Reddy’s biopharmaceutical manufacturing set-up more flexible and efficient, strengthening... Read more

Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey

BOSTON, May 17, 2017 – Partners HealthCare and GE Healthcare today announced a 10-year collaboration to rapidly develop, validate and strategically integrate deep learning technology across the entire continuum of care. The collaboration will be executed through the newly formed Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science and will... Read more

MilliporeSigma’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune

 Accelerates development timelines with faster, easier selection and scale up of clones  Delivers higher titers of recombinant proteins Billerica, Massachusetts, May 16, 2017 — MilliporeSigma today announced that its CHOZN® expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic. The CHOZN® expression system is designed... Read more

Thermo Fisher Scientific to Acquire Patheon, a Leading Contract Development and Manufacturing Organization (CDMO)

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Patheon N.V. (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, today announced that their boards of directors have approved Thermo Fisher’s acquisition of Patheon. Thermo Fisher will commence a tender offer... Read more